JFG
PALI icon

Jefferies Financial Group’s Palisade Bio PALI Stock Holding History

Jefferies Financial Group’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$61K Sell
34,875
-11,886
-25% -$21.6K ﹤0.01% 1637
2025
Q4 		$110K Buy
+46,761
New +$89.9K ﹤0.01% 1693

Other funds holding PALI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Jefferies Financial Group's PALI Position: Q1 2026 in Review

Jefferies Financial Group reduced its Palisade Bio (PALI) stake by 25% in Q1 2026, selling an estimated $21.6K and leaving 34,875 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #1637.

Jefferies Financial Group first reported a position in PALI in Q4 2025 and has held it in 2 quarters since. The position peaked at $110K in Q4 2025. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

  • Jefferies Financial Group held 34,875 shares of Palisade Bio worth $61K as of Q1 2026.
  • Jefferies Financial Group sold 11,886 Palisade Bio shares in Q1 2026, an estimated $21.6K.
  • Palisade Bio made up ﹤0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #1637 holding.
  • Jefferies Financial Group first reported a position in Palisade Bio in Q4 2025 and has held it in 2 quarters since.
  • Jefferies Financial Group's Palisade Bio position peaked at $110K in Q4 2025.
  • 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.